Skip to main content
Erschienen in: Intensive Care Medicine 1/2016

01.01.2016 | What's New in Intensive Care

Does this patient have acute kidney injury? An AKI checklist

verfasst von: John A. Kellum, Rinaldo Bellomo, Claudio Ronco

Erschienen in: Intensive Care Medicine | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Imagine receiving a call from a colleague asking for some help evaluating a patient in the emergency department. The patient is 66 years old and apart from some osteoarthritis is in excellent health. She has not seen a physician for several years. She now has fever, cough, and a right lower lobe infiltrate. The doctor has started antibiotics and given some IV fluid but he is concerned about a serum creatinine of 1.3 mg/dl and oliguria (voided only 20 ml in the last 2 h). …
Literatur
2.
Zurück zum Zitat Kdigo AKI Workgroup (2012) Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Inter Suppl 2012(2):1–138 Kdigo AKI Workgroup (2012) Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Inter Suppl 2012(2):1–138
3.
Zurück zum Zitat Hoste EAJ, Bagshaw SM, Bellomo R et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 8:1411–1423. doi:10.1007/s00134-015-3934-7 CrossRef Hoste EAJ, Bagshaw SM, Bellomo R et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 8:1411–1423. doi:10.​1007/​s00134-015-3934-7 CrossRef
8.
Zurück zum Zitat Kemperman FA, Silberbusch J, Slaats EH et al (2000) Follow-up of GFR estimated from plasma creatinine after cimetidine administration in patients with diabetes mellitus type 2. Clin Nephrol 54:255–260PubMed Kemperman FA, Silberbusch J, Slaats EH et al (2000) Follow-up of GFR estimated from plasma creatinine after cimetidine administration in patients with diabetes mellitus type 2. Clin Nephrol 54:255–260PubMed
9.
Zurück zum Zitat Levey AS, Eckardt K-U, Tsukamoto Y et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100CrossRefPubMed Levey AS, Eckardt K-U, Tsukamoto Y et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100CrossRefPubMed
10.
11.
Zurück zum Zitat Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212PubMedCentralCrossRefPubMed Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Závada J, Hoste E, Cartin-Ceba R et al (2010) A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transpl 25:3911–3918CrossRef Závada J, Hoste E, Cartin-Ceba R et al (2010) A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transpl 25:3911–3918CrossRef
13.
Zurück zum Zitat Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25PubMedCentralCrossRefPubMed Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Kellum JA, Devarajan P (2014) What can we expect from biomarkers for acute kidney injury? Biomark Med 8:1239–1245CrossRefPubMed Kellum JA, Devarajan P (2014) What can we expect from biomarkers for acute kidney injury? Biomark Med 8:1239–1245CrossRefPubMed
15.
Zurück zum Zitat Koyner JL, Shaw AD, Chawla LS, Hoste EAJ, Bihorac A, Kashani K et al (2015) Tissue inhibitor metalloproteinase-2 (TIMP-2)·IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 26:1747–1754CrossRefPubMed Koyner JL, Shaw AD, Chawla LS, Hoste EAJ, Bihorac A, Kashani K et al (2015) Tissue inhibitor metalloproteinase-2 (TIMP-2)·IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 26:1747–1754CrossRefPubMed
16.
Zurück zum Zitat Bihorac A, Chawla LS, Shaw AD et al (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189:932–939CrossRefPubMed Bihorac A, Chawla LS, Shaw AD et al (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189:932–939CrossRefPubMed
Metadaten
Titel
Does this patient have acute kidney injury? An AKI checklist
verfasst von
John A. Kellum
Rinaldo Bellomo
Claudio Ronco
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 1/2016
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-4026-4

Weitere Artikel der Ausgabe 1/2016

Intensive Care Medicine 1/2016 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.